Runben Biotechnology released its performance for the first three quarters, with a net profit attributable to the parent company of 266 million yuan, a year-on-year increase of 1.98%Zhitong·Oct 20, 2025 at 05:09 AM603193-1.79%
Runben Biotechnology 2025 Half-Year Equity Distribution: Cash Dividend of 0.2 Yuan per ShareZhitong·Sep 11, 2025 at 03:41 AM603193-1.79%
Runben Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 188 million yuan, an increase of 4.16%Zhitong·Aug 18, 2025 at 06:05 AM603193-1.79%
This week's largest increase in margin financing balance: Runben Biotechnology margin financing balance: 326 million yuan, balance increase: 147.62%; SOKAN margin financing balance: 125 million yuan, balance increase: 103.81%Zhitong·Aug 3, 2025 at 07:20 AM688157+1.98%603193-1.79%
Global Growth Companies With High Insider Ownership To WatchSimplywall·Jul 23, 2025 at 04:35 AM603193-1.79%09863-0.45%
The beauty and personal care sector rises, Runben Biotechnology hits the limit upZhitong·Jul 23, 2025 at 12:54 AM603193-1.79%300886+2.10%
Runben Biotechnology: Plans to invest 600 million yuan to build a Runben biotechnology research and production base projectZhitong·May 6, 2025 at 05:08 AM603193-1.79%
3 Global Growth Companies With High Insider Ownership Expecting Up To 27% Revenue GrowthSimplywall·Apr 29, 2025 at 06:41 AM603193-1.79%300548+10.40%
Runben Biotechnology released its first-quarter performance, with a net profit attributable to the parent company of 44.2 million yuan, a year-on-year increase of 24.60%Zhitong·Apr 24, 2025 at 05:34 AM603193-1.79%
Runben Biotechnology: JNRY VIII's shareholding ratio has decreased to 5%Zhitong·Apr 16, 2025 at 04:05 AM603193-1.79%
Asian Growth Companies With High Insider Ownership In March 2025Simplywall·Mar 30, 2025 at 05:16 PM603193-1.79%688266+4.00%
Runben Biotechnology's major shareholder JNRY VIII plans to reduce its holdings by no more than 3%Zhitong·Mar 18, 2025 at 07:24 AM603193-1.79%
Runben Biotechnology's major shareholder JNRY VIII has completed a 3% share reductionZhitong·Feb 10, 2025 at 04:38 AM603193-1.79%
Runben Biotechnology issued a profit forecast, expecting an annual net profit of 300 million to 310 million yuan, a year-on-year increase of 32.73% to 37.15%Zhitong·Jan 22, 2025 at 02:05 AM603193-1.79%
Runben Biotechnology: JNRY VIII has cumulatively reduced its holdings by 1.36%Zhitong·Jan 8, 2025 at 04:15 AM603193-1.79%
